Outcome of Board Meeting held on May 20, 2026 as per SEBI (LODR) Regulations, 2015

MedPlus Health Services reported strong FY2026 results with consolidated revenue growing 12.3% to Rs. 68,924.66 million (from Rs. 61,360.53 million). Profit after tax surged 46.2% to Rs. 2,196.06 million from Rs. 1,502.33 million in the prior year, driven by growth in retail and diagnostic segments. The company allotted 82,419 equity shares under ESOP 2021, increasing paid-up capital to Rs. 240.11 million. Board changes include completion of tenure for two Independent Directors (Madhavan Ganesan and Murali Sivaraman from June 10, 2026), appointment of two new Independent Directors (Ajit Pandurang Rangnekar and Mohankrishna Reddy Arvabumi), and re-appointment of Managing Director Gangadi Madhukar Reddy for five years from August 2026. The Company Secretary resigned, and cost auditor M P R & Associates was re-appointed for FY2027. The statutory auditor B S R and Co issued an unmodified (clean) opinion on both standalone and consolidated financial statements.